- This topic has 0 replies, 1 voice, and was last updated 1 year, 4 months ago by
.
Viewing 0 reply threads
-
Posts
-
-
The HOPE-2 trial has been cleared by an independent review board to resume testing CAP-1002 therapy on boys and young men with Duchenne muscular dystrophy. Read more about it here.
What do you think of this news?
-
Viewing 0 reply threads
- You must be logged in to reply to this topic.
